We are currently seeing a revival of interest in Aquinas's moral thought among Christian ethicists, both Protestant and Catholic. Although recent studies of his moral thought have touched on a number of topics, the majority of these have focused on his account of the virtues and their place in the Christian life. Probing the questions of the relation of virtue and law, the role of reason and will, and the place of the passions in Aquinas's moral theology, I will examine (...) recent studies by Diana Cates, Pamela Hall, Simon Harak, James Keenan, Daniel Nelson, Daniel Westberg, and Paul Waddell. In different ways these studies return us repeatedly to the vexed and unresolved question of the scope of human freedom. (shrink)

At the request of the Classical Journals Board we have undertaken for the present to edit this Journal. In so doing we confidently rely upon the co-operation of those who have hitherto been contributors, as well as of others who may be in a position to assist us.

MS. 124 in the library of St. John Baptist College, Oxford, is a quarto of 154 pages, written in two or more hands of the fifteenth century. Its provenance is unknown, and, as it has been carefully and ruthlessly rebound at some time in the nineteenth century, it is impossible to derive any information from the binding. After an unusually elabbrate alphabetical index it bears on folio 11 an inscription in a seventeenth-century hand as follows: ‘Libellus Thomae de Walsingham De (...) generacione naturaque deorum simul cum interpretatione Ouidii Metamorphoseon Simoni Priori Sancti Albani dedicatus.’. (shrink)

Readers of Phaedrus will have noticed that the rhythm of III. Ep. 34, Palam muttire plebeio piaculum est is unique. Nowhere else does he admit a molossus-word before the final metron of the iambic senarius, and he only admits it here because he is quoting a line from the Telephus of Ennius. Since a scholar whose opinion deserves respect proposes to introduce this rhythm into a reconstruction of a fragment of Laberius it seems worth while to examine its history in (...) order to see how and why it was used, before it was finally banned. For Seneca, like Phaedrus, banns it entirely. The question has already been considered by Klotz, Grundzüge Altrömischer Metrik, pp. 324 sqq.; W. M. Lindsay, Captiui , p. 66; Havet, Métrique, 276 ; and by T. Hingst in his inaugural dissertation De Spondeis et Anapaestis in antepaenultimo pede uersuum generis duplicis Latinorum, Leipzig, 1904. (shrink)

The bear, says Hierocles, is aware that its head is easily injured, and instinctively uses its paws as a protection. The three following lines in the papyrus are badly damaged– καν εί π.ε … δεηθεί Του | βαλανεíον κρημν | πáλιν ύ;β εθεíησιν ε | αυΤήν. This is followed by a description of what the bear does when it is pursued and comes to a precipice. It inflates itself and trusts to the inflation to break its fall. It is hardly (...) possible to restore the damaged lines. Von Arnim thinks that the sense required is: ‘wenn die Bärin, vom Jäger verfolgt, eines Bades bedarf oder auf ihrer Flucht an einen Abgrund kommt,πáλιν ύπ èψίησιν εαψτήν’ But a sensible bear would hardly think of taking a bath when pursued by the hunter. It might take to the water; but the Greek for this would be somewhat different. As I read the passage, there is no reference to the bear as pursued by the hunter till line 34, where I would read πоιεî δè τò τοιóνδε , since the phrase εί δ υν διοκμéνμ in line 38 is resumptive, and implies that the pursuit must have been alluded to before. But before line 35 H. is only describing what the bear does to protect its head in the ordinary routine of its life when it is not harassed by the hunter. It wants a bath, and finds that it cannot reach the water without clambering down an overhanging bank It will not climb down head foremost, but guards its head by sliding backwards down the bank. As the bear would want its bath because it was hot, it is perhaps not too hazardous to conjecture that some phrase such as xs03F0xs2135ν ει π ε<ζομéν πνíγηι δεμθεíν του β. should find its place in line 31. (shrink)

It would add greatly to our interest in the plays of Plautus if we knew more about the order in which they were produced. As it is, our knowledge of the dates of the plays is pitifully meagre and uncertain. Miles Gloriosus appears to have been produced soon after 206; Cistellaria about 201; Stichus in 200; Trinummus soon after 194; Pseudolus probably is 191, and Truculentus about 189. The date of the remaining seventeen plays is unknown. We can only infer (...) their relation one to another from the internal evidence of language, metre, and structure. The results of an examination on these lines, if they converged, might be useful in enabling us to arrange the plays roughly in a number of well-defined groups. Mr. Sedgwick 1 has recently made an interesting attempt to approach the problem from the side of metre. I think that a more intensive study of the plays from the side of language might lead to profitable results. My immediate concern is, however, only with a small corner of this vast field—viz., the frequent coincidence of thought and phrase which is so marked a feature of these plays. (shrink)

1. A World of Difference: Travel Narratives and the Inscription of Culture -- 2. Fair Texts/Dark Ladies: Renaissance Lyric and the Poetics of Color -- 3. "Commerce and Intercourse": Dramas of Alliance and Trade -- 4. The Daughters of Eve and the Children of Ham: Race and the English Woman Writer -- 5. "An Object in the Midst of Other Objects": Race, Gender, Material Culture -- Epilogue: Oil "Race," Black Feminism, and White Supremacy -- Appendix: Poems of Blackness.

A critical account of the key connections between twentieth-century French philosopher Gilles Deleuze and nineteenth-century German idealist G. W. F. Hegel. Hegel, Deleuze, and the Critique of Representation provides a critical account of the key connections between twentieth-century French philosopher Gilles Deleuze and nineteenth-century German idealist G. W. F. Hegel. While Hegel has been recognized as one of the key targets of Deleuze’s philosophical writing, Henry Somers-Hall shows how Deleuze’s antipathy to Hegel has its roots in a problem the two (...) thinkers both try to address: getting beyond a philosophy of judgment and the restrictions of Kant’s transcendental idealism. By tracing the development of their attempts to address this problem, Somers-Hall offers an interpretation of the sweep of nineteenth- and twentieth-century philosophy, providing a series of analyses of key moments in the history of thought, including the logics of Aristotle and Russell, Kant’s own philosophy of judgment, and the philosophy of Bergson. He also develops a novel interpretation of Deleuze’s philosophy of difference, and situates his philosophy in relation to the broader post-Kantian tradition. In addition to Deleuze’s relation to Hegel, the book makes important contributions to the study of Deleuze’s philosophy of mathematics, as well as to the study of several underappreciated areas of Hegel’s own philosophy. (shrink)

This article evaluates the oversight of drugs and medical devices by the U.S. Food and Drug Administration using an integration of public policy, law, and bioethics approaches and employing multiple assessment criteria, including economic, social, safety, and technological. Criteria assessment and expert elicitation are combined with existing literature, case law, and regulations in an integrative historical case studies approach. We then use our findings as a tool to explore possibilities for effective oversight and regulatory mechanisms for nanobiotechnology. Section I describes (...) oversight mechanisms for human drugs and medical devices and presents current nanotechnology products. Section II describes the results of expert elicitation research. Section III highlights key criteria and relates them to the literature and larger debate. We conclude with broad lessons for the oversight of nanobiotechnology informed by Sections I-III in order to provide useful analysis from multiple disciplines and perspectives to guide discussions regarding appropriate FDA oversight. (shrink)

This article evaluates the oversight of drugs and medical devices by the U.S. Food and Drug Administration using an integration of public policy, law, and bioethics approaches and employing multiple assessment criteria, including economic, social, safety, and technological. Throughout, assessments employing both the multiple criteria and a method of expert elicitation are combined with the existing literature, case law, and regulations providing an integrative historical case study approach. The goal is to provide useful information from multiple disciplines and perspectives to (...) guide discussions regarding appropriate oversight frameworks for nanobiotechnology applications under the FDA’s purview. (shrink)

Nanomedicine is yielding new and improved treatments and diagnostics for a range of diseases and disorders. Nanomedicine applications incorporate materials and components with nanoscale dimensions where novel physiochemical properties emerge as a result of size-dependent phenomena and high surface-to-mass ratio. Nanotherapeutics and in vivo nanodiagnostics are a subset of nanomedicine products that enter the human body. These include drugs, biological products, implantable medical devices, and combination products that are designed to function in the body in ways unachievable at larger scales. (...) Nanotherapeutics andin vivonanodiagnostics incorporate materials that are engineered at the nanoscale to express novel properties that are medicinally useful. These nanomedicine applications can also contain nanomaterials that are biologically active, producing interactions that depend on biological triggers. Examples include nanoscale formulations of insoluble drugs to improve bioavailability and pharmacokinetics, drugs encapsulated in hollow nanoparticles with the ability to target and cross cellular and tissue membranes and to release their payload at a specific time or location, imaging agents that demonstrate novel optical properties to aid in locating micrometastases, and antimicrobial and drug-eluting components or coatings of implantable medical devices such as stents. (shrink)